ArticleNucleic acids research2026
DNAviWEB: sequencing-free clinical screening of liquid biopsies.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Noninvasive cell-free DNA (cfDNA) fragmentation profiles are gaining popularity as diagnostic tools for a wide range of conditions contributing to the global health burden, such as cancer, autoinflammatory disorders, and adverse events in pregnancy or transplantation. Despite their diagnostic value, fragmentomics rely on DNA sequencing, resulting in significant costs and turnaround times, therefore limiting their translation to everyday clinical care. Here, we present DNAviWEB (https://dnavi.sc.hpi.de/), a freely accessible implementation of the DNAvi analysis tool for exploring cfDNA fragmentomics from DNA gel electrophoresis in research settings. DNAviWEB enables instant presequencing analysis of cfDNA while integrating into medical workflows by providing browsable European Genome-phenome Archive and European Liquid Biopsy Society metadata catalogs and delivering rich outputs of patient group-stratified cfDNA statistics, visualizations, and secure storage capacities for clinical data. The DNAviWEB platform opens the exploration, analysis, and database deposition of liquid biopsy DNA profiles to a broad community of clinicians and researchers. DNAviWEB is free and open source.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.